Positive Persistent Visual Symptoms (Visual Snow) Presenting as a Migraine Variant in a 12-Year-Old Girl
Pediatr Neurol 49:361-363, Simpson, J.C.,et al, 2013
Clinical and MRI characteristics of acute migrainous infarction
Neurol 76:1911-1917, Wolf, M.E.,et al, 2011
Migraine with Aura Triggered by Cardiac Myxoma: Case Report and Literature Review
Cephalalgia 30:1396-1399, Ceuster, L.,et al, 2010
Migraine and Cardiovascular Disease: Systematic Review and Meta-Analysis
BMJ 339:b3914, Sch�rks,M.,et al, 2009
Migraine with Aura Is a Risk Factor for Unprovoked Seizures in Children
Ann Neurol 59:210-213, Ludvigsson,P.,et al, 2006
Migraine and Risk of Cardiovascular Disease in Women
JAMA 296:283-291,333, Kurth,T.,et al, 2006
Left Atrial Myxoma Presenting as Migraine with Aura: A VIP-induced Syndrome
Headache 45:251-254, Kern, R. & Asa, S., 2005
CADASIL: Cerebral Autosomal Subcortical Infarcts and Leukoecephalopathy
, Chabriat, H., Joutel A., Vahedi, K., Tournier-Lasserve, &E., Bousser M.G., 2004
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Pract Neurology 4:50-55, Razvi,S.S.M. &Muir,K.W., 2004
Acetazolamide Treatment for Migraine Aura Status
Neurol 55:1588-1589, Haan,J.,et al, 2000
Perfusion-Weighted Imaging Defects During Spontaneous Migrainous Aura
Ann Neurol 43:25-31, Cutter,F.M.,et al, 1998
Familial Acephalgic Migraines
Neurol 48:776-777, Shevell,M.I., 1997
Successful Treatment of Persistent Migraine Aura with Divalproex Sodium
Neurol 48:261-262, Rothrock,J.F., 1997
MRI During Migraine with Aura
J Comput Assist Tomogr 20:228-229, McNeal,A.C., 1996
History of Migraine and Risk of Cerebral Ischaemia in Young Adults
Lancet 347:1503-1506, Carolei,A.,et al, 1996
Persistent Positive Visual Phenomena in Migraine
Neurol 45:664-668, Liu,G.T.,et al, 1995
Familial Acephalgic Migraine
Neurol 45:2293-2294, Ziegler,D.K., 1995
Diagnosing the Severe Headache
Neurol 44:S6-S12, Dalessio,D.J., 1994
Subcutaneous Sumatriptan During the Migraine Aura
Neurol 44:1587-1592, Bates,D.,et al, 1994
Migraine-Related Seizures in Adults with Epilepsy, With EEG Correlation
Neurol 43:2476-2483, Marks,D.A.&Ehrenberg,B.L., 1993
Migraine and Migranous Stroke:Risk Factors and Prognosis
Neurol 43:2473-2476, Rothrock,J.,et al, 1993
Classical Migraine:Symptoms Between Visual Aura and Headache Onset
Lancet 340:355-356, Blau,J.N., 1992
The Fortification Spectra of Migraine
BMJ 293:1613-1617, Plant,G.T., 1987
Olfactory Aura in Migraine
NEJM 312:1390-1391, Diamond,S.,et al, 1985
Prolonged Migraine Aura Status
Ann Neurol 11:197-199, Haas,D.C., 1982
Abdominal Epilepsy
JAMA 222:65, Babb,R.,et al, 1972
Genetic Causes of Cerebral Small Vessel Diseases, A Parctical Guide for Neurologists
Neurol 100:766-783, Manini,A.,&Pantoni,L., 2023
Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023
Acute Treatment for Migraine
JAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021
Atogepant for the Preventive Treatment of Migraine
NEJM 385:695-706, Ailani,J.,et al, 2021
Burning Pain in the Legs
NEJM 383:e18, Sacks, C.A., 2020
One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
Migraine, hearing loss, and blurred vision in a young woman
Neurol 95:e2945-e2950, Sasikumar, S.,et al, 2020
Factors Associated with Risk of Recurrent Transient Global Amnesia
JAMA Neurol 77:1551-1558, Morris, K.A.,et al, 2020
Cyclic Vomiting Syndrome in Children
AJGH 2:doi:10.33552/AJGH.2020, Al-Ansari, N., 2020
Encephalopathy in a Large Cohort of British Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients
Stroke 50:283-290, Drazyk, A.M.,et al, 2019
A Woman in her 40s with Transient Neurological Symptoms, Migraine Headaches, and Hearing Loss
JAMA Neurol 76:504-505, Roshal, D.A.,et al, 2019
Erenumab in Chronic Migraine
Neurol 92:e2250-e2260, Lipton, R.B.,et al, 2019
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Remigepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
NEJM 381:142-149, Lipton, R.B.,et al, 2019
Vestibular Migraine
BMJ 366:L4213, Li, V.,et al, 2019
Treatment Effects and Comorbid Diseases in 58 Patients with Visual Snow
Neurol 93:e398-e403, vanDongen, R.M.,et al, 2019
Acute Treatment of Migraine in Children and Adolescents
Neurol 93:487-499, Oskoui, M.,et al, 2019
Pharmacologic Treatment for Pediatric Migraine Prevention
Neurol 93:500-509, Oskoui, M.,et al, 2019
Fremanezumab versus Placebo for Migraine Prevention in Patients with Documented Failure to Up to Four Migraine Preventive Medication Classes (FOCUS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3� Trial
Lancet 394:1030-1040, Ferrari, M.D.,et al, 2019
Acute Vestibular Migraine Treatment with Noninvasive Vagus Nerve Stimulation
Neurol 93:e1715-e1719, Beh, S.C. & Friedman, D.I., 2019
Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019
Ubrogepant for the Treatment of Migraine
NEJM 381:2230-2241, Dodick, D.W.,et al, 2019